Phase 3 study for people with painful, highly inflammatory condition initiated by Galapagos April 28, 2023 AutoBot News 0 Galapagos NV has announced it has initiated a phase 3 study with small molecule drug filgotinib in patients with the chronic, highly inflammatory condition, active axial spondyloarthritis(AxSpA).